Publications

Found 1 results
Filters: Author is C.-H. Hsieh  [Clear All Filters]
2011
C. - H. Hsieh, Pei, D., Hung, Y. - J., and Hsiao, F. - C., Association between retinoid-X receptor-gamma genetic polymorphisms and diabetic retinopathy, vol. 10, pp. 3545-3551, 2011.
Anonymous (1997). Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 46: 1829-1839. http://dx.doi.org/10.2337/diabetes.46.11.1829 PMid:9356033   Anonymous (1998a). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. Lancet 352: 837-853. http://dx.doi.org/10.1016/S0140-6736(98)07019-6   Anonymous (1998b). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317: 703-713. http://dx.doi.org/10.1136/bmj.317.7160.703 PMid:9732337 PMCid:28659   Awata T, Inoue K, Kurihara S, Ohkubo T, et al. (2002). A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51: 1635-1639. http://dx.doi.org/10.2337/diabetes.51.5.1635 PMid:11978667   Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I and Jozwiak L (2007). Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol. Dial. Transplant. 22: 827-832. http://dx.doi.org/10.1093/ndt/gfl641 PMid:17121786   Cahill GF Jr, Etzwiler LD and Freinkel N (1976). Editorial: "Control" and diabetes. N. Engl. J. Med. 294: 1004-1005. http://dx.doi.org/10.1056/NEJM197604292941811 PMid:1256496   Chai D, Wang B, Shen L, Pu J, et al. (2008). RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radic. Biol. Med. 44: 1334-1347. http://dx.doi.org/10.1016/j.freeradbiomed.2007.12.022 PMid:18206668   Chen Y, Huang H, Zhou J, Doumatey A, et al. (2007). Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol. Vis. 13: 2142-2147. PMid:18079690   Davies PJ, Berry SA, Shipley GL, Eckel RH, et al. (2001). Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. Mol. Pharmacol. 59: 170-176. PMid:11160850   Fong DS, Aiello L, Gardner TW, King GL, et al. (2003). Diabetic retinopathy. Diabetes Care 26: 226-229. http://dx.doi.org/10.2337/diacare.26.1.226 PMid:12502685   Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, et al. (1998). Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41: 47-53. http://dx.doi.org/10.1007/s001250050865 PMid:9498629   Hsieh CH, Liang KH, Hung YJ, Huang LC, et al. (2006). Analysis of epistasis for diabetic nephropathy among type 2 diabetic patients. Hum. Mol. Genet. 15: 2701-2708. http://dx.doi.org/10.1093/hmg/ddl203 PMid:16893912   Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, et al. (2007). Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 30: 292-299. http://dx.doi.org/10.2337/dc06-1747 PMid:17259497   Kastner P, Mark M and Chambon P (1995). Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83: 859-869. http://dx.doi.org/10.1016/0092-8674(95)90202-3   Klein R, Klein BE, Moss SE, Davis MD, et al. (1984a). The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 102: 520- 526. http://dx.doi.org/10.1001/archopht.1984.01040030398010 PMid:6367724   Klein R, Klein BE, Moss SE, Davis MD, et al. (1984b). The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Ophthalmol. 102: 527- 532. http://dx.doi.org/10.1001/archopht.1984.01040030405011 PMid:6367725   Knowler WC, Coresh J, Elston RC, Freedman BI, et al. (2005). The family investigation of nephropathy and diabetes (FIND): design and methods. J. Diabetes Complications 19: 1-9. http://dx.doi.org/10.1016/j.jdiacomp.2003.12.007 PMid:15642484   Lesile RD and Pyke DA (1982). Diabetic retinopathy in identical twins. Diabetes 31: 19-21. http://dx.doi.org/10.2337/diabetes.31.1.19   Mangelsdorf DJ and Evans RM (1995). The RXR heterodimers and orphan receptors. Cell 83: 841-850. http://dx.doi.org/10.1016/0092-8674(95)90200-7   Parving HH, Tarnow L and Rossing P (1996). Genetics of diabetic nephropathy. J Am. Soc. Nephrol. 7: 2509-2517. PMid:8989728   Ray D, Mishra M, Ralph S, Read I, et al. (2004). Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 53: 861-864. http://dx.doi.org/10.2337/diabetes.53.3.861 PMid:14988276   Reiner AP, Agardh E, Teramura G, Gaur P, et al. (2003). Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis. Thromb. Haemost. 89: 142-148. PMid:12540964   Roy MS, Hallman DM, Fu YP, Machado M, et al. (2009). Assessment of 193 candidate genes for retinopathy in African Americans with type 1 diabetes. Arch. Ophthalmol. 127: 605-612. http://dx.doi.org/10.1001/archophthalmol.2009.48 PMid:19433708   Shulman AI and Mangelsdorf DJ (2005). Retinoid x receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 353: 604-615. http://dx.doi.org/10.1056/NEJMra043590 PMid:16093469   Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, et al. (2006). Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol. Vis. 12: 336-341. PMid:16636650